Bayer launches Delaro® Complete fungicide, delivering a powerful multi-mode of action solution for corn, soybean, and cereal farmers

May 11, 2021

Guelph, ON – The Crop Science division of Bayer announced that Delaro® Complete has been registered for use in Eastern Canada on corn, soybeans and cereals. The new foliar fungicide delivers effective and consistent control of major corn, soybean, and cereals diseases.

“Delaro Complete adds to the proven performance of Stratego® PRO for even better control of the most important corn, soybean, and cereal diseases.” says Eric Comte, Soybean & Pulse Crop and Campaign Marketing Manager, Bayer. “The addition of Fluopyram is ideal for high disease pressure situations and offers residual protection, giving farmers an extra edge heading into the end of the season.”

Delaro Complete has three modes of action (Groups 3, 11, 7) that work in tandem for added protection. In corn, Delaro Complete provides excellent preventive defenses against yield robbing diseases such as common rust, eye spot, Northern corn leaf blight and tar spot. In soybeans, Delaro Complete protects against all major soybean diseases as well as providing enhanced suppression of white mould.

“The three modes of action provide excellent disease control under various environmental conditions and work together to combat the toughest diseases,” says Comte.

Delaro Complete is available to Eastern Canadian farmers for the 2021 growing season. Farmers are encouraged to talk to their local Bayer representative to learn more, or visit CropScience.Bayer.ca.

Source : BayerCropScience

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.